Lopinavir/Ritonavir Accord

Medicinal product

(Invented) name

Lopinavir/Ritonavir Accord

Active substance (s)

Lopinaviras/Ritonaviras

Strength

200 mg/50 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

J05AR10, Lopinavir and ritonavir

Marketing authorisation holder

Accord Healthcare B.V., Nyderlandai

Date of authorisation

2017-02-13

Date of renewal

2022-02-08

Documents

4045 Lopinavis_Ritonavir Accord II PL 2022 10 19.docx

4045 Pakuotės lapelis 2022 10 19.docx

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

NL/H/3142/001/E/001

Marketing authorisation procedure

Kartotinė procedūra

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Lopinaviras	200 mg
Ritonaviras	50 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
67721	82277	1082277	lizdinė plokštelė	N60		Receptinis	LT/1/17/4045/001	Netiekiama	-	-	No	-	-
67722	82278	1082278	lizdinė plokštelė	N120		Receptinis	LT/1/17/4045/002	Netiekiama	-	-	No	-	-
67723	82279	1082279	lizdinė plokštelė	N120 (3x40)		Receptinis	LT/1/17/4045/003	Netiekiama	-	-	No	-	-
67724	82280	1082280	buteliukas	N120		Receptinis	LT/1/17/4045/004	Netiekiama	-	-	No	-	-
67725	82281	1082281	buteliukas	N360 (3x120)		Receptinis	LT/1/17/4045/005	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2022-12-29	Išregistruotas
2022-02-08	Perregistruotas
2017-02-13	Registruotas